Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics

Acta Diabetologica

Volumn 43, Issue 1, 2006, Pages 14-18

  Akbar, D H ^a,b   Ahmed, M M ^a   Al Mughales, J ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b NONE   (Saudi Arabia)

Author keywords

GAD65ab; Saudi; Thyroid autoimmunity; Thyroid dysfunction; Type 2 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE 65;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SAMPLE; SAUDI ARABIA; SCREENING; SEX DIFFERENCE; STATISTICAL ANALYSIS; THYROID DISEASE;

AUTOIMMUNITY; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SAUDI ARABIA; THYROID DISEASES; THYROID GLAND;

EID: 33646860995     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-006-0204-8     Document Type: Article

References (34)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes. Diabetes Care 27:1047-1053
2. Alzaid A (1997) Time to declare war on diabetes. Ann Saudi Med 17:154-155
3. Al-Nuaim AR, Al Mazrou Y, Al Attas O, Al Rubean K, Khoja T, Al Daghari N (1995) National chronic metabolic disease survey part 1, prevalence of diabetes mellitus, obesity, hyperlipidemia in Saudi Arabia, 1st Edn. Ministry of Health, Riyadh (KSA), pp 1-75
4. Fatani H, Mira S, Elzubeir AG (1987) Prevalence of diabetes mellitus in rural Saudi Arabia. Diabetes Care 10:180-183
5. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F (1997) The spectrum of thyroid disease in the community: the Whickham survey. Clin Endocrinol 19:481-493
6. Feely J, Isles TE (1979) Screening for thyroid dysfunction in diabetics. Br Med J 1:1678
7. Gray RS, Irvine WJ, Clarke BF (1979) Screening for thyroid dysfunction in diabetics. Br Med J 2:1439
8. Smithson MJ (1998) Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med 15:148-150
9. Perros P, McCrimmon RJ, Shaw G, Frier BM (1995) Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 12:622-627
10. Celani MF, Bonati ME, Stucci N (1994) Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Diabetes Res 27:15-25
11. Menon PS, Vaidyanathan B, Kaur M (2001) Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 14:279-286
12. Park YS, Kim TW, Kim WB, Cho BY (2000) Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J Intern Med 15:202-210
13. Lorini R, d'Annunzio G, Vitali L, Scaramuzza A (1996) IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab 9[Suppl 1]:89-94
14. Burek CL, Rose NR, Guire KE, Hoffman WH (1990) Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 7:157-167
15. Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL (1981) Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 99:350-354
16. Matejkova-Behanova M, Zamrazil V, Vondra K, Vrbikova J, Kucera P, Hill M, Andel M (2002) Autoimmune thyroiditis in non-obese subjects with initial diagnosis of Type 2 diabetes mellitus. J Endocrinol Invest 25:779-784
17. Matejkova-Behanova M (2001) Latent autoimmune diabetes in adults (LADA) and autoimmune thyroiditis. Endocr Regul 35:167-172
18. Jin P, Zhou ZG, Yang L, Yan X, Wang JP, Zhang DM, Huang G (2004) Adult-onset latent autoimmune diabetes and autoimmune thyroid disease. Zhonghua Nei Ke Za Zhi 43:363-367
19. Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF, Weetman AP (1998) A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clin Endocrinol 49:609-613
20. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K (1997) Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82:4130-4132
21. Gottsaeter A, Lernmark Å, Landin-Olsson M, Sundkvist G, Fernlund P (1993) b-Cell function in relation to islet cell antibodies during the first 3 years after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902-910
22. Littorin B, Sundkvist G, Hagopian W, Landin-Olsson M, Lernmark Å, Ostman J, Arnqvist HJ, Blohme G, Bolinder J, Eriksson JW, Lithner F, Schersten B, Wibell L (1999) Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. Diabetes Care 22:409-412
23. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303
24. Bosi EP, Garancini MP, Poggiali F, Bonifacio E, Gallus G (1999) Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. Diabetologia 42:840-844
25. Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A (2000) Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 52:565-573
26. Kucera P, Novakova D, Behanova M, Novak J, Tlaskalova-Hogenova H, Andel M (2003) Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA). Clin Exp Immunol 133:139-143
27. Tuomi T, Carlsson A, Li HY, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157
28. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ (1995) GAD antibodies in NIDDM-10-year follow-up from the diagnosis. Diabetes Care 18:1557-1565
29. Panz VR, Kalk WJ, Zouvanis M, Joffe BI (2000) Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa. Diabet Med 17:524-529
30. Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y (1997) Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Exp Clin Endocrinol Diabetes 105:327-330
31. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR (1993) Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362
32. Cardoso C, Ohwovoriole AE, KuKu SF (1995) A study of thyroid function and prevalence of thyroid autoantibodies in an African diabetic population. J Diabetes Complications 9:37-41
33. Lindholm E, Hallengren B, Agardh CD (2004) Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab Res Rev 20:158-164
34. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 43:55-68